A new preprint reports significantly associated findings that may help predict severe long COVID and understand what causes it.
Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules | Psychedelic Invest
VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer,